Cryoport and Minaris Regenerative Medicine, a global contract development and manufacturing organization for cell and gene therapies, announced a strategic partnership to provide fully integrated logistics and manufacturing services to biotechnology and pharmaceutical companies for regenerative medicine products to support the advancement of cell and gene therapies. The collaboration combines Cryoport’s experience in meeting the logistics needs of the life sciences industry and Minaris’ expertise in contract manufacturing of regenerative medicine products including stem cells, gene therapy, biomaterials and engineered tissue.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CYRX:
Questions or Comments about the article? Write to editor@tipranks.com